Come up with a name for your new list and we'll add to it:
Stoke Therapeutics raised a round of funding on January 04, 2018. Investors include
Apple Tree Partners.
Stoke Therapeutics is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for the treatment of severe genetic diseases. Stoke's NextGen RNAseq yields wh…